Table 3.
Persistent angina pectoris as a predictor of outcome on adjusted analysis
| Endpoint | Adjusteda hazard ratio (95% confidence interval) | P-value |
|---|---|---|
| Death/myocardial infarction/revascularization | 1.30 (1.08–1.57) | 0.006 |
| Death/myocardial infarction | 1.17 (0.95–1.44) | 0.14 |
| Death | 1.14 (0.92–1.41) | 0.23 |
| Cardiovascular death/cardiovascular hospitalization | 1.36 (1.14–1.62) | 0.0006 |
| All-cause death/all-cause hospitalization | 1.33 (1.13–1.56) | 0.0006 |
a
Adjusted for age, sex, race, hypertension, diabetes, prior myocardial infarction, hyperlipidaemia, NYHA class, cerebrovascular disease, peripheral vascular disease, previous smoking history, ventricular gallop, Charlson Index, body mass index, heart rate, systolic blood pressure, use of beta-blocker, ACE inhibitor, or ARB, hydralazine, nitrates, calcium channel blocker, aspirin, clopidogrel, statin, diuretic, and serum creatinine, sodium, blood urea nitrogen, haemoglobin, percutaneous coronary intervention or coronary artery bypass grafting within 1 year of index catheterization.